Embolization of Pelvic Veins in Treatment of Pelvic Congestion Syndrome

Pelvic Congestive Syndrome Clinical Trial

Official title:

Effectiveness of Embolization of Pelvic Veins in Treatment of Pelvic Congestion Syndrome

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03165214
• Other study ID #: PCS
• Status: Withdrawn
• Phase: N/A
• Start date: July 1, 2017
• Est. completion date: September 2019

Study information

• Verified date: August 2020
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Chronic pelvic pain is defined as chronic or persistent pain perceived in structures related to the pelvis of either men or women for more than 6 months according to The International Association for the Study of Pain. In other words, chronic pelvic pain with associated ovarian vein varicosities is termed pelvic congestion syndrome and is an important but under-diagnosed condition

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: September 2019
• Est. primary completion date: July 2019
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 20 Years to 50 Years

Eligibility

Inclusion Criteria:

• Clinical symptoms of pelvic congestion syndrome documented by Doppler ultrasound

• Failed medical treatment.

Exclusion Criteria:

• Endometriosis.

• Uterine fibroids.

• Previous pelvic operations.

• Urological diseases.

Related Conditions & MeSH terms

• Pelvic Congestive Syndrome
• Syndrome

Intervention

Device:
• coil
microcoils
• hystoacryl glue
hystoacryl mixed with lipidol

Locations

Country	Name	City	State
Egypt	Ahmed Abbas	Assiut	Cairo
Egypt	Assiut Faculty of Medicine	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The number of treated patients with different interventions		6 months